Meningitis and pneumonia in Guatemalan children: The importance of Haemophilus influenzae type b and Streptococcus pneumoniae

Revista Panamericana de Salud Publica/Pan American Journal of Public Health

Volumn 14, Issue 6, 2003, Pages 377-384

  Asturias, Edwin J ^a,b   Soto, Monica ^c   Menendez, Ricardo ^d   Ramirez, Patricia L ^c   Recinos, Fabio ^e   Gordillo, Remei ^d   Holt, Elizabeth ^a   Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Ctr for Disease Studies and Control   (Guatemala)

^c Hospital General San Juan de Dios Guatemala   (Guatemala)

^d Roosevelt Hospital Guatemala   (Guatemala)

^e Hosp Gen Inst Guatemalteco S S   (Guatemala)

Author keywords

Guatemala; Haemophilus; Haemophilus influenzae type b; Meningitis; Streptococcus pneumoniae; Vaccination

Indexed keywords

CHILD HEALTH; HEALTH STATUS; MENINGITIS; PNEUMONIA;

ANTIGEN DETECTION; ARTICLE; BACTERIAL MENINGITIS; BACTERIAL PNEUMONIA; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM IDENTIFICATION; CEREBROSPINAL FLUID ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; GUATEMALA; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; LATEX AGGLUTINATION TEST; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PLEURA FLUID; PRESCHOOL CHILD; PREVALENCE; SENSITIVITY AND SPECIFICITY; STREPTOCOCCUS PNEUMONIAE;

CENTRAL AMERICA; GUATEMALA [CENTRAL AMERICA];

EID: 1642474134     PISSN: 10204989     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1020-49892003001100002     Document Type: Article

References (25)

1. Adams WG, Deaver KA, Cochi SL, Plikaytis BD, Zell ER, Broome CV, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993;269(2):221-226.
2. Broome CV. Epidemiology of Haemophilus influenzae type b infections in the United States. Pediatr Infect Dis J 1987;6(8):779-782.
3. Cochi SL, Broome CV, Hightower AW. Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA 1985;253(4):521-529.
4. Peltola H. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microb Rev 2000;13:302-317.
5. Levine OS, Schwartz B, Pierce N, Kane M. Development, evaluation and implementation of Haemophilus influenzae type b vaccines for children in developing countries: current status and priority actions. Pediatr Infect Dis J 1998:17:S95-112.
6. Levine OS, Lagos R, Munoz A, Villaroel J, Alvarez AM, Abrego P, et al. Defining the burden of pneumonia in children preventable by vaccination against Haemophilus influenzae type b. Pediatr Infect Dis J 1999;18(12):1060-1064.
7. Peltola H. Haemophilus influenzae type b disease and vaccination in Latin America and the Caribbean. Pediatr Infect Dis J 1997;16(8):780-787.
8. Peltola H. Need for Haemophilus influenzae type b vaccination in Asia as evidenced by epidemiology of bacterial meningitis. Pediatr Infect Dis J 1998;17(9 Suppl): S148-151.
9. Mulholland K, Hilton S, Adegbola R, Usen S, Oparaugo A, Omosigho C, et al. Randomised trial of Haemophilus influenzae type-b tetanus protein conjugate vaccine for prevention of pneumonia and meningitis in Gambian infants. Lancet 1997;349(9060):1191-1197.
10. Salih MA, Khaleefa OH, Bushara M, Taha ZB, Musa ZA, Kamil I, et al. Long term sequelae of childhood acute bacterial meningitis in a developing country. A study from the Sudan. Scand J Infect Dis 1991;23(2):175-182.
11. World Health Organization. Antimicrobial and support therapy for bacterial meningitis in children: report of the meeting of 18-20 June, 1997, Geneva, Switzerland. Geneva: WHO; 1998. Available from: http://www.who.intemc-documents/meningitis/whoemcbac982c.html [Internet site]. Accessed 19 February 2001.
12. Molyneux E, Walsh A, Phiri A, Molyneux M. Acute bacterial meningitis in children admitted to the Queen Elizabeth Central Hospital, Blantyre, Malawi in 1996-97. Trop Med Int Health 1998;3(8):610-618.
13. Mulholland EK, Adegbola RA. The Gambian Haemophilus influenzae type b vaccine trial: what does it tell us about the burden of Haemophilus influenzae type b disease? Pediatr Infect Dis J 1998;17(9 Suppl): S123-125.
14. Levine OS, Schuchat A, Schwartz B, Wenger JD, Elliot J. Generic protocol for population-based surveillance of Haemophilus influenzae type b. Geneva: World Health Organization, Global Programme for Vaccines and Immunization; 1997. (WHO/VRD/GEN/95.05).
15. Limcangco MR, Salole EG, Armour CL. Epidemiology of Haemophilus influenzae type b meningitis in Manila, Philippines, 1994 to 1996. Pediatr Infect Dis J 2000; 19(1):7-11.
16. Dagan R, Fraser D, Greif Z, Keller N, Kaufstein M, Shazberg G, et al. A nationwide prospective surveillance study in Israel to document pediatric invasive infections, with an emphasis on Haemophilus influenzae type b infections. Israeli Pediatric Bacteremia and Meningitis Group. Pediatr Infect Dis J 1998;17(9 Suppl): S198-203.
17. Shoma S, Rahman M, Yasmin M. Rapid detection of Haemophilus influenzae type b in Bangladeshi children with pneumonia and meningitis by PCR and analysis of antimicrobial resistance. J Health Popul Nut 2001;19(4):268-274.
18. Feldman WE. Effect of prior antibiotic therapy on concentrations of bacteria in CSF. Am J Dis Child 1978;132(7):672-674.
19. Ajello GW, Bolan GA, Hayes PS, Lehmann D, Montgomery J, Feeley JC, et al. Commercial latex agglutination tests for detection of Haemophilus influenzae type b and Streptococcus pneumoniae antigens in patients with bacteremic pneumonia. J Clin Microbiol 1987;25(8):1388-1391.
20. Rubin LG, Carmody L. Pneumococcal and Haemophilus influenzae type b antigen detection in children at risk for occult bacteremia. Pediatrics 1987;80(1):92-96.
21. Boersma WG, Lowenberg A, Holloway Y, Kuttschrutter H, Snijder JA, Koeter GH. Rapid detection of pneumococcal antigen in pleural fluid of patients with community acquired pneumonia. Thorax 1993; 48(2):160-162.
22. Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, et al. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile. Am J Epidemiol 1993;137(11):1221-1228.
23. Lagos R, Levine OS, Avendano A, Horwitz I, Levine MM. The introduction of routine Haemophilus influenzae type b conjugate vaccine in Chile: a framework for evaluating new vaccines in newly industrializing countries. Pediatr Infect Dis J 1998;17(9 Suppl):S139-148.
24. Wenger JD, DiFabio JL, Landaverde JM, Levine OS, Gaafar T. Introduction of Hib conjugate vaccines in the non-industrialized world: experience of four 'newly adopting' countries. Vaccine 1999;18:736-742.
25. Mulholland K, Levine O, Nohynek H, Greenwood BM. Evaluation of vaccines for the prevention of pneumonia in children in developing countries. Epidemiol Rev 1999;21(1):43-55.